Cargando…

Cancer dormancy: time to explore its clinical relevance

Dormant disseminated cancer cells, arrested and nonproliferating, are “good” cancer cells because there is no need to worry unless they resume growth. The mechanisms by which dormant disseminated cancer cells are put to sleep at distant sites and re-awakened are poorly understood. Moreover, it is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Gužvić, Miodrag, Klein, Christoph A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979111/
https://www.ncbi.nlm.nih.gov/pubmed/24359585
http://dx.doi.org/10.1186/bcr3590
_version_ 1782310689243660288
author Gužvić, Miodrag
Klein, Christoph A
author_facet Gužvić, Miodrag
Klein, Christoph A
author_sort Gužvić, Miodrag
collection PubMed
description Dormant disseminated cancer cells, arrested and nonproliferating, are “good” cancer cells because there is no need to worry unless they resume growth. The mechanisms by which dormant disseminated cancer cells are put to sleep at distant sites and re-awakened are poorly understood. Moreover, it is not clear whether re-awakened cancer cells have a role in disease courses. Cyrus Ghajar and colleagues identified a mechanism of dormancy and growth resumption that might become important when more closely linked to clinical reality.
format Online
Article
Text
id pubmed-3979111
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39791112014-06-20 Cancer dormancy: time to explore its clinical relevance Gužvić, Miodrag Klein, Christoph A Breast Cancer Res Viewpoint Dormant disseminated cancer cells, arrested and nonproliferating, are “good” cancer cells because there is no need to worry unless they resume growth. The mechanisms by which dormant disseminated cancer cells are put to sleep at distant sites and re-awakened are poorly understood. Moreover, it is not clear whether re-awakened cancer cells have a role in disease courses. Cyrus Ghajar and colleagues identified a mechanism of dormancy and growth resumption that might become important when more closely linked to clinical reality. BioMed Central 2013 2013-12-20 /pmc/articles/PMC3979111/ /pubmed/24359585 http://dx.doi.org/10.1186/bcr3590 Text en Copyright © 2013 BioMed Central Ltd.
spellingShingle Viewpoint
Gužvić, Miodrag
Klein, Christoph A
Cancer dormancy: time to explore its clinical relevance
title Cancer dormancy: time to explore its clinical relevance
title_full Cancer dormancy: time to explore its clinical relevance
title_fullStr Cancer dormancy: time to explore its clinical relevance
title_full_unstemmed Cancer dormancy: time to explore its clinical relevance
title_short Cancer dormancy: time to explore its clinical relevance
title_sort cancer dormancy: time to explore its clinical relevance
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979111/
https://www.ncbi.nlm.nih.gov/pubmed/24359585
http://dx.doi.org/10.1186/bcr3590
work_keys_str_mv AT guzvicmiodrag cancerdormancytimetoexploreitsclinicalrelevance
AT kleinchristopha cancerdormancytimetoexploreitsclinicalrelevance